Michael Benkowitz
2018
In 2018, Michael Benkowitz earned a total compensation of $6.6M as President and Chief Operating Officer at United Therapeutics, a 43% decrease compared to previous year.
Compensation breakdown
| Change in Pension Value and Nonqualified Deferred Compensation Earnings | $835,680 |
|---|---|
| Non-Equity Incentive Plan | $1,083,750 |
| Option Awards | $3,839,015 |
| Salary | $833,333 |
| Other | $17,480 |
| Total | $6,609,258 |
Benkowitz received $3.8M in option awards, accounting for 58% of the total pay in 2018.
Benkowitz also received $835.7K of change in pension value and nonqualified deferred compensation earnings, $1.1M in non-equity incentive plan, $833.3K in salary and $17.5K in other compensation.
Rankings
In 2018, Michael Benkowitz's compensation ranked 1,366th out of 14,244 executives tracked by ExecPay. In other words, Benkowitz earned more than 90.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,366 out of 14,244 | 90th |
Division Manufacturing | 476 out of 5,758 | 92nd |
Major group Chemicals And Allied Products | 150 out of 2,119 | 93rd |
Industry group Drugs | 117 out of 1,808 | 94th |
Industry Pharmaceutical Preparations | 85 out of 1,382 | 94th |
Source: SEC filing on April 29, 2019.
Benkowitz's colleagues
We found three more compensation records of executives who worked with Michael Benkowitz at United Therapeutics in 2018.